Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
OtherEndocrine and Diabetes

The novel phosphate and bile acid sequestrant polymer SAR442357 delays disease progression in a rat model of diabetic nephropathy

Tamara R. Castañeda, María Méndez, Ian Davison, Ralf Elvert, Uwe Schwahn, Galina Boldina, Corinne Rocher, Petra Scherer, Kuldeep Singh, Dinesh Bangari, Mechthilde Falkenhan, Aimo Kannt, Anish Konkar, Philip J. Larsen, Cynthia Arbeeny, Pradeep K. Dhal and Thomas Hübschle
Journal of Pharmacology and Experimental Therapeutics November 20, 2020, JPET-AR-2020-000285; DOI: https://doi.org/10.1124/jpet.120.000285
Tamara R. Castañeda
1Sanofi-Aventis Deutschland GmbH, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
María Méndez
1Sanofi-Aventis Deutschland GmbH, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ian Davison
2C&BD Haverhill Operations, Sanofi GB Genzyme Limited, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ralf Elvert
1Sanofi-Aventis Deutschland GmbH, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Uwe Schwahn
1Sanofi-Aventis Deutschland GmbH, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Galina Boldina
3Sanofi R&D Translational Sciences France, Bioinformatics, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Corinne Rocher
3Sanofi R&D Translational Sciences France, Bioinformatics, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Petra Scherer
1Sanofi-Aventis Deutschland GmbH, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kuldeep Singh
4Sanofi Global Discovery Pathology, United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dinesh Bangari
4Sanofi Global Discovery Pathology, United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mechthilde Falkenhan
1Sanofi-Aventis Deutschland GmbH, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aimo Kannt
1Sanofi-Aventis Deutschland GmbH, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anish Konkar
5Sanofi-Aventis Deutschland GmBH, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philip J. Larsen
1Sanofi-Aventis Deutschland GmbH, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cynthia Arbeeny
1Sanofi-Aventis Deutschland GmbH, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pradeep K. Dhal
6Sanofi Global R&D Pharmaceutical Development Platform, United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Hübschle
7R&D, Sanofi-Aventis Deutschland GmbH, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Thomas Hübschle
  • For correspondence: Thomas.Huebschle@sanofi.com
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Figures & Data

Additional Files

  • Data Supplement

    • Supplemental Data -

      Supplemental Table 1. Optimization of epichlorohydrin crosslinked PAA-PDA copolymer hydrogel networks to identify SAR442357.

      Supplemental Figure S1. SAR442357: (A) Schematic representation of the synthesis of copolymer sequestrants by epichlorohydrin mediated crosslinking of PAA and PDA; and (B) 2-dimensional 13C-1H cross correlation NMR spectrum of SAR442357.

      Supplemental Figure S2. Gene expression Volcano plots.

      Supplemental Figure S3. Gene expression heatmap.

      Supplemental Figure S4. Serum liver safety parameters at study end after 3 months of treatment.

      Supplemental Figure S5. Serum and urine uric acid at study end after 3 months of treatment.

      Supplemental Figure S6. Kidney histology depicting tubule pathology in corticomedullary junction region.

      Supplemental Figure S7. The serum biomarkers of chronic tubular damage serum urea and serum creatinine at study end after 3 months of treatment.

PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 376 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 376, Issue 2
1 Feb 2021
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The novel phosphate and bile acid sequestrant polymer SAR442357 delays disease progression in a rat model of diabetic nephropathy
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
OtherEndocrine and Diabetes

A novel polymeric sequestrant delays diabetic nephropathy

Tamara R. Castañeda, María Méndez, Ian Davison, Ralf Elvert, Uwe Schwahn, Galina Boldina, Corinne Rocher, Petra Scherer, Kuldeep Singh, Dinesh Bangari, Mechthilde Falkenhan, Aimo Kannt, Anish Konkar, Philip J. Larsen, Cynthia Arbeeny, Pradeep K. Dhal and Thomas Hübschle
Journal of Pharmacology and Experimental Therapeutics November 20, 2020, JPET-AR-2020-000285; DOI: https://doi.org/10.1124/jpet.120.000285

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
OtherEndocrine and Diabetes

A novel polymeric sequestrant delays diabetic nephropathy

Tamara R. Castañeda, María Méndez, Ian Davison, Ralf Elvert, Uwe Schwahn, Galina Boldina, Corinne Rocher, Petra Scherer, Kuldeep Singh, Dinesh Bangari, Mechthilde Falkenhan, Aimo Kannt, Anish Konkar, Philip J. Larsen, Cynthia Arbeeny, Pradeep K. Dhal and Thomas Hübschle
Journal of Pharmacology and Experimental Therapeutics November 20, 2020, JPET-AR-2020-000285; DOI: https://doi.org/10.1124/jpet.120.000285
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • NMDA Receptor Antagonists and β-Cells
  • The Roles of Oleoylethanolamide in Hepatic Glycometabolism
Show more Article

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics